Alliance Pharma Plc (APH):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Alliance Pharma Plc (APH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9767
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alliance Pharma Plc (Alliance) is a specialty pharmaceutical company. It focuses on acquisition, licensing, registration and marketing of pharmaceutical products. It promotes acquired and licensed prescription products across various therapeutic categories such as dermatology, central nervous system, women’s health, infectious disease, cardiovascular, respiratory, immunology, gastrointestinal, oncology, nutrition, toxicology and mouth and dental disorders. The company distributes its products through wholesalers, retail pharmacies, hospitals and international network of distributors. It operates in the UK, Ireland, British Virgin Islands, France and Germany. Alliance is headquartered in Chippenham, Wiltshire, the UK.

Alliance Pharma Plc (APH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alliance Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Alliance Pharma Acquires Nizoral from Janssen Pharma for USD79.5 Million 11
Alliance Pharma Acquires Rights of Vamousse from TyraTech 12
Alliance Pharma Acquires Healthcare Products Business from Sinclair IS Pharma for USD198.4 Million 13
Alliance Pharma Acquires Rights of Nutraceutical Brands from Sinopharm Nutraceuticals for USD2.1 Million 14
Alliance Pharma Acquires Rights To Irenat From Bayer 15
Alliance Pharma Acquires Rights To Lypsyl From Novartis For US$3 Million 16
Alliance Pharma Acquires Overseas Rights To Syntometrine From Novartis For US$11.5 Million 17
Alliance Pharma Acquires Antimalarial Drug Brands From AstraZeneca UK For US$8 Million 18
Alliance Pharma Completes Acquisition Of UK And Irish Rights To Anbesol And Ashton & Parsons From Reckitt Benckiser For US$4 Million 19
Licensing Agreements 20
Alliance Pharma Enters into Licensing Agreement with Duchesnay for Diclectin 20
Equity Offering 21
Alliance Pharma Raises USD45 Million in Private Placement of Shares 21
Alliance Pharma Raises USD7.6 Million in Private Placement of Shares 22
Acquisition 23
Pacific Glory Development to Acquire 60% Stake in Unigreg for USD4 Million 23
Alliance Pharma Acquires MacuVision 24
Alliance Pharma Acquires Opus, Healthcare Products Distributor, For US$15.3 Million 25
Alliance Pharma Plc – Key Competitors 26
Alliance Pharma Plc – Key Employees 27
Alliance Pharma Plc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Financial Announcements 30
Sep 19, 2018: Alliance Pharma announces interim results for the six months ended 30 June 2018 30
Jul 25, 2018: Alliance Pharma: half year trading update 37
Mar 27, 2018: APH Full Year Results 38
Mar 27, 2018: Alliance Pharma: Results for the year ended 31 December 2017 39
Sep 13, 2017: Alliance Pharma: Interim Results for the six months ended 30 June 2017 44
Jul 18, 2017: Alliance Pharma: Half Year Trading Update 45
Mar 29, 2017: Alliance Pharma: Results for the year ended 31 December 2016 46
Jan 23, 2017: Alliance Pharma Announces Pre-Close Trading Update 47
Corporate Communications 48
May 30, 2018: Alliance Pharma: Directorate Change 48
Mar 01, 2018: Alliance Pharma: Directorate Changes 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alliance Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alliance Pharma Plc, Deals By Therapy Area, 2012 to YTD 2018 9
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alliance Pharma Acquires Nizoral from Janssen Pharma for USD79.5 Million 11
Alliance Pharma Acquires Rights of Vamousse from TyraTech 12
Alliance Pharma Acquires Healthcare Products Business from Sinclair IS Pharma for USD198.4 Million 13
Alliance Pharma Acquires Rights of Nutraceutical Brands from Sinopharm Nutraceuticals for USD2.1 Million 14
Alliance Pharma Acquires Rights To Irenat From Bayer 15
Alliance Pharma Acquires Rights To Lypsyl From Novartis For US$3 Million 16
Alliance Pharma Acquires Overseas Rights To Syntometrine From Novartis For US$11.5 Million 17
Alliance Pharma Acquires Antimalarial Drug Brands From AstraZeneca UK For US$8 Million 18
Alliance Pharma Completes Acquisition Of UK And Irish Rights To Anbesol And Ashton & Parsons From Reckitt Benckiser For US$4 Million 19
Alliance Pharma Enters into Licensing Agreement with Duchesnay for Diclectin 20
Alliance Pharma Raises USD45 Million in Private Placement of Shares 21
Alliance Pharma Raises USD7.6 Million in Private Placement of Shares 22
Pacific Glory Development to Acquire 60% Stake in Unigreg for USD4 Million 23
Alliance Pharma Acquires MacuVision 24
Alliance Pharma Acquires Opus, Healthcare Products Distributor, For US$15.3 Million 25
Alliance Pharma Plc, Key Competitors 26
Alliance Pharma Plc, Key Employees 27
Alliance Pharma Plc, Subsidiaries 28

List of Figures
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★海外企業調査レポート[Alliance Pharma Plc (APH):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Volkswagen AG:企業の戦略・SWOT・財務分析
    Volkswagen AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sumitomo Corp (8053):企業の財務・戦略的SWOT分析
    Sumitomo Corp (8053) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Corus Entertainment Inc. (CJR.B):企業の財務・戦略的SWOT分析
    Corus Entertainment Inc. (CJR.B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • ING Group NV:企業のM&A・事業提携・投資動向
    ING Group NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ING Group NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • NPO Petrovax Pharm LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NPO Petrovax Pharm LLC (Petrovax) focuses on the research, development and manufacturing of medicines and vaccines. The company’s expertise spans in producing APIs and liquid, semi-solid, and solid dosage forms in ampoules, plastic containers, vials and disposable syringes. It also provides …
  • Westar Energy Inc:企業の発電所・SWOT分析2018
    Westar Energy Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • The Wendy’s Company:企業の戦略・SWOT・財務情報
    The Wendy’s Company - Strategy, SWOT and Corporate Finance Report Summary The Wendy’s Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • China Gas Holdings Ltd (384):石油・ガス:M&Aディール及び事業提携情報
    Summary China Gas Holdings Ltd (CGHL) is a gas operator and service provider. The company offers piped natural gas, compressed natural gas, liquid petroleum gas and liquefied natural gas. Its activities include construction and operation of gas stations, gas pipeline infrastructure facilities, gas t …
  • Serodus ASA (SER)-製薬・医療分野:企業M&A・提携分析
    Summary Serodus ASA (Serodus) is a drug development company that focuses on the development of products for unmet medical needs in areas such as diabetes and diabetic comorbidities. The company’s pipeline products include SER150DN, an anti-inflammatory compound under development for diabetic nephrop …
  • Dirk Rossmann GmbH:企業の戦略・SWOT・財務情報
    Dirk Rossmann GmbH - Strategy, SWOT and Corporate Finance Report Summary Dirk Rossmann GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Red Robin Gourmet Burgers Inc:企業の戦略・SWOT・財務情報
    Red Robin Gourmet Burgers Inc - Strategy, SWOT and Corporate Finance Report Summary Red Robin Gourmet Burgers Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Mitsubishi Chemical Holdings Corporation:企業の戦略・SWOT・財務分析
    Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Ingram Micro Inc.:企業のM&A・事業提携・投資動向
    Ingram Micro Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ingram Micro Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Spectrum Pharmaceuticals Inc (SPPI)-製薬・医療分野:企業M&A・提携分析
    Summary Spectrum Pharmaceuticals Inc (Spectrum) is a biotechnology company that develops and commercializes a pipeline of late-stage clinical and commercial products with focus on hematology and oncology. The company’s marketed drugs include Fusilev (levoleucovorin); Folotyn (pralatrexate injection) …
  • Johnson Controls International Plc (JCI):企業の財務・戦略的SWOT分析
    Johnson Controls International Plc (JCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • LifeNet Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary LifeNet Health Inc (LifeNet Health) is a non-profit organization that specializes in regenerative medicine. It offers allograft bio-implants and organs for transplantation. The organization specializes in offering organ procurement, tissue banking and transplant services. It provides allogra …
  • Norfolk Southern Corporation:企業の戦略・SWOT・財務情報
    Norfolk Southern Corporation - Strategy, SWOT and Corporate Finance Report Summary Norfolk Southern Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Resources Connection Inc (RECN):企業の財務・戦略的SWOT分析
    Summary Resources Connection Inc (Resources Connection) operates as a consultancy firm that offers consulting and business initiative support services. The firm offers services such as change management, finance and accounting services, merger and acquisition transaction services, program and projec …
  • United Therapeutics Corporation:企業の戦略・SWOT・財務分析
    United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report Summary United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Science Applications International Corp:企業の戦略・SWOT・財務分析
    Science Applications International Corp - Strategy, SWOT and Corporate Finance Report Summary Science Applications International Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆